Classes
Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Alirocumab, Praluent(R) in the light of studies2016 | First Faculty of Medicine
- The effect of simvastatin and fenofibrate on the expression of leukocyte adhesion molecules and lipopolysaccharide receptor CD14 in type 2 diabetes mellitus2012 | First Faculty of Medicine
- Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy2012 | First Faculty of Medicine
- Combo therapy for reaching of LDL-C target2012 | First Faculty of Medicine
- Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?2011 | First Faculty of Medicine
- Therapeutic equivalence of the generic and the reference atorvastatin in patients with increased coronary risk2011 | First Faculty of Medicine
- SHARP study from the perspective lipidologa2011 | First Faculty of Medicine
- Commentary to Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: a therapeutic dilemma2010 | First Faculty of Medicine
- Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia2010 | First Faculty of Medicine
Loading network view...